These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 23319753)

  • 1. Q&A: Mina Bissell on tumors as organs.
    Bissell M
    Cancer Discov; 2013 Jan; 3(1):7. PubMed ID: 23319753
    [No Abstract]   [Full Text] [Related]  

  • 2. In honor of Mina J. Bissell.
    Barcellos-Hoff MH
    Integr Biol (Camb); 2011 Apr; 3(4):253-4. PubMed ID: 21448491
    [No Abstract]   [Full Text] [Related]  

  • 3. An outsider's perspective--ecotaxis revisited: an integrative review of cancer environment, iron and immune system cells.
    de Sousa M
    Integr Biol (Camb); 2011 Apr; 3(4):343-9. PubMed ID: 21180734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic microenvironment of tumor cells: a key factor in malignant progression.
    Vaupel P
    Exp Oncol; 2010 Sep; 32(3):125-7. PubMed ID: 21403604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming of the tumor.
    Ferreira LM; Hebrant A; Dumont JE
    Oncogene; 2012 Sep; 31(36):3999-4011. PubMed ID: 22231450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ecology of Tumors: By perturbing the microenvironment, wounds and infection may be key to tumor development.
    Kenny PA; Nelson CM; Bissell MJ
    Scientist; 2006 Apr; 20(4):30. PubMed ID: 21132085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mina J. Bissell: Context Matters.
    Trends Cancer; 2015 Sep; 1(1):6-8. PubMed ID: 28741563
    [No Abstract]   [Full Text] [Related]  

  • 8. Mast cell: insight into remodeling a tumor microenvironment.
    Liu J; Zhang Y; Zhao J; Yang Z; Li D; Katirai F; Huang B
    Cancer Metastasis Rev; 2011 Jun; 30(2):177-84. PubMed ID: 21267769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation.
    Yao D; Dai C; Peng S
    Mol Cancer Res; 2011 Dec; 9(12):1608-20. PubMed ID: 21840933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.
    Danhier F; Feron O; Préat V
    J Control Release; 2010 Dec; 148(2):135-46. PubMed ID: 20797419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
    Gillet JP; Gottesman MM
    Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
    [No Abstract]   [Full Text] [Related]  

  • 12. Antineoplastic activities of Gd@C₈₂(OH)₂₂ nanoparticles: tumor microenvironment regulation.
    Li Y; Tian Y; Nie G
    Sci China Life Sci; 2012 Oct; 55(10):884-90. PubMed ID: 23108865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypoxic microenvironment and cancer dormancy].
    Okuyama H; Inoue M
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1559-64. PubMed ID: 21996947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eicosanoids and other lipid mediators and the tumor hypoxic microenvironment.
    Krishnamoorthy S; Honn KV
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):613-8. PubMed ID: 22042480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic instability induced by the tumor microenvironment.
    Reynolds TY; Rockwell S; Glazer PM
    Cancer Res; 1996 Dec; 56(24):5754-7. PubMed ID: 8971187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stochastic gene expression stabilization as a new therapeutic strategy for cancer.
    Capp JP
    Bioessays; 2012 Mar; 34(3):170-3. PubMed ID: 22231918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β-induced epithelial-mesenchymal transition: a link between cancer and inflammation.
    Fuxe J; Karlsson MC
    Semin Cancer Biol; 2012 Oct; 22(5-6):455-61. PubMed ID: 22627188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material.
    Lotfi R; Eisenbacher J; Solgi G; Fuchs K; Yildiz T; Nienhaus C; Rojewski MT; Schrezenmeier H
    Eur J Immunol; 2011 Jul; 41(7):2021-8. PubMed ID: 21538978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of T-cell responses by tumor metabolites.
    Singer K; Gottfried E; Kreutz M; Mackensen A
    Cancer Immunol Immunother; 2011 Mar; 60(3):425-31. PubMed ID: 21240484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-κB and the link between inflammation and cancer.
    DiDonato JA; Mercurio F; Karin M
    Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.